KPCB XV ASSOCIATES, LLC Holdings

KPCB XV ASSOCIATES, LLC is an investment fund managing more than 35.84M US dollars. The largest holdings include RAPT Therapeutics, Twilio and Atara Biotherapeutics. In Q2 2021 the fund bought assets of total value of 10.56M US dollars and sold assets of total value of 20.9M US dollars.

KPCB XV ASSOCIATES, LLC portfolio value:

$35.83M
portfolio value

KPCB XV ASSOCIATES, LLC quarter portfolio value change:

-5.12%
quarter

KPCB XV ASSOCIATES, LLC 1 year portfolio value change:

-61.81%
1 year

KPCB XV ASSOCIATES, LLC portfolio changes

Portfolio changes (number of shares)
Period Buy Sel
Q2 2021 10556000 20895000

KPCB XV ASSOCIATES, LLC 13F holdings

Stock
Portfolio share: 43.54%
Portfolio value: 15.60M
Avg. open price: N/A
Current price: $17.6
P/L: N/A
Sold -50.00% shares
Q3 2022
Portfolio share: 36.66%
Portfolio value: 13.14M
Avg. open price: $298.66
Current price: $48.64
P/L: -83.71%
Bought +1.00% shares
Q1 2022
Portfolio share: 19.79%
Portfolio value: 7.09M
Avg. open price: N/A
Current price: $4.76
P/L: N/A
N/A
Q4 2020
Portfolio share: 0.00%
Portfolio value: 0
Avg. open price: N/A
Current price: $1.14
P/L: N/A
Sold -100.00% shares
Q3 2022

Showing TOP 4 KPCB XV ASSOCIATES's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of KPCB XV ASSOCIATES, LLC?

The biggest position of the KPCB XV ASSOCIATES, LLC is RAPT Therapeutics, Inc. (RAPT) with 43.54% portfolio share worth of 15.6M US dollars.

Who is the portfolio manager of KPCB XV ASSOCIATES, LLC?

The portfolio manager of the KPCB XV ASSOCIATES, LLC is .

What is the total asset value of the KPCB XV ASSOCIATES, LLC portfolio?

KPCB XV ASSOCIATES, LLC total asset value (portfolio value) is 35.84M US dollars.

Who is ?

is the portfolio manager of the KPCB XV ASSOCIATES, LLC.

What is (KPCB XV ASSOCIATES, LLC) fund performance?

KPCB XV ASSOCIATES's quarterly performance is -5.12%, annualy -61.81%.

What is the KPCB XV ASSOCIATES, LLC CIK?

KPCB XV ASSOCIATES's Central Index Key is 0001547838 .